Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial-Reference-Cited by-同舟云学术

Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial

Published:2017-12 Issue:10111 Volume:390 Page:2472-2480
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Jin Celina,Gibani Malick M,Moore Maria,Juel Helene B,Jones Elizabeth,Meiring James,Harris Victoria,Gardner Jonathan,Nebykova Anna,Kerridge Simon A,Hill Jennifer,Thomaides-Brears Helena,Blohmke Christoph J,Yu Ly-Mee,Angus Brian,Pollard Andrew J

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment;Mogasale;Lancet Glob Heal,2014

2. Typhoid fever and paratyphoid fever: systematic review to estimate global morbidity and mortality for 2010;Buckle;J Glob Health,2012

3. An appraisal of the clinical features of paediatric enteric fever including a systematic review and meta-analysis of the age stratified disease occurence;Britto;Clin Infect Dis,2017

4. The global burden of typhoid fever;Crump;Bull World Health Organ,2004

5. Precise estimation of the numbers of chronic carriers of Salmonella typhi in Santiago, Chile, an endemic area;Levine;J Infect Dis,1982

Cited by 243 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing;International Journal of Biological Macromolecules;2024-10

2. Interplay Between the Gut Microbiome and Typhoid Fever: Insights from Endemic Countries and a Controlled Human Infection Model;2024-09-03

3. The use of controlled human infection models to identify correlates of protection for invasive Salmonella vaccines;Frontiers in Immunology;2024-08-27

4. IDENTIFYING PLAUSIBLE RANGES FOR DIFFERENTIAL VACCINE EFFICACY ACROSS HIGH- AND LOW-INCOME SETTINGS: A SYSTEMATIC REVIEW, DESCRIPTIVE META-ANALYSIS, AND ILLUSTRATIVE EVIDENCE ANALYSIS;2024-08-01

5. Next-generation vaccines for tropical infectious diseases;International Journal of Infectious Diseases;2024-06